Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine v. Ketorolac for Management of Generalized Tension Type Headache


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03221569

Organisation Name: The Brooklyn Hospital Center

Overal Status: Unknown status

Start Date: February 1, 2016

Last Update: July 6, 2018

Lead Sponsor: The Brooklyn Hospital Center

Brief Summary: The hypothesis of the study is that sub-dissociative dose ketamine will prove to be superior to or as standard therapy, ketorolac, in the treatment of acute tension type headache (TTH) as measured by the 10 point Numerical Rating Scale (NRS. The aim of the study is to compare the safety & efficacy of intravenous sub-dissociative dose ketamine versus ketorolac for acute treatment of migraines in the Emergency Department (ED) The primary endpoints are: Patient perception of pain as described by the use the Numerical Rating Scale (NRS) at 30 minutes.

The secondary endpoints are: Frequency and mean dose of rescue/additional doses of therapy at 15, 30, 45, 60, 75, 90 min, Number of emergency department re-visits for acute migraine one month post discharge, incidence of dissociative effects (characterized by hallucination, disorientation, confusion, agitation, delirium, dreams) during study period, incidence of nausea, vomiting, or worsening headache, Incidence of bad taste, Incidence of burning sensations in the nostrils, incidence of hypertension, time to patient discharge from the initiation of study medication/placebo, patient satisfaction of pain control based on a Likert Scale.

Conditions:
  • Migraine


Total execution time in seconds: 0.15026092529297